Delex Healthcare Group Inc (ID) (DELX)

DELX

.007s gone easily and super thin on the ask.

DELX will going to go BIG this time. Let's just wait and see.

.007s getting eaten up, once they are gone this goes over .01 easily

DELX took some more this AM, looks like we are getting ready to start a huge run on 8Ks/PRs now with the ticker changed and r/m finalized

Bounce Mobile Systems, Inc. (BNCM) Announces Corporate Name Change to Delex Healthcare Group Inc. (DELEX) and New Ticker Symbol “DELX”

https://www.otcmarkets.com/stock/DELX/news/BNCM-Announces-Corporate-Name-Change-to-Delex-Healthcare-and-New-Ticker-Symbol-DELX?id=522431

Going to be a lot more eyes on this soon.

Hearing some very big moves are coming here; I'm loading.

Lots of upside potential once the .007s finally clear out.

Name and ticker change completed - all is moving forward nicely here.

Bounce Mobile Systems Inc., BNCM, changed to Delex Healthcare Group Inc., DELX

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

04/27/2026 OTCID Market LogoBNCM Bounce Mobile Systems, Inc. Pink Limited OTCID

Annual filed

https://www.otcmarkets.com/file/company/financial-report/551830/content

That puts the "10m" in "revs" at 590,000 USD Lol. Dismal pump.

2024 financials are in philippine pesos

Conversion rate today is $59.08 PHP to $1 USD

RIP BNCM

Sounds like the 2025 projection plans with no results from 2025 . Maybe good idea would be to merge with # 1 or #2 pharm chain to dominate the market . How many pham did they open in 2025 ? , supposed to open 10 to 20 .

BNCM: DELEX CORPORATE ACTIONS & EXPANSION PLANS FOR 2026
Press Release
OTC Disclosure & News Service | 02/09/2026
February 2026 — BNCM today provided an update on its ongoing corporate actions and the growth outlook of Delex Healthcare Group, Inc. (DELEX), a profitable pharmaceutical and healthcare company with a strong presence in the Philippines.

Name and Ticker Symbol Change

BNCM has submitted applications for its corporate name change to Delex Healthcare Group and ticker symbol change to DELEX with the U.S. Securities and Exchange Commission (SEC) and the Financial Industry Regulatory Authority (FINRA), respectively. Shareholders will be informed upon receipt of regulatory approvals.

Company Background

Founded in 2009, Delex Pharma International, Inc. has over 15 years of experience developing and distributing affordable, high-quality critical care medications. The company has established one of the most extensive pharmaceutical distribution networks in the Philippines, serving hospitals, pharmacies, and healthcare professionals nationwide.

Management and Market Position

DELEX is led by a seasoned management team with decades of combined experience across local and multinational pharmaceutical companies. Their expertise spans sales, marketing, operations, regulatory affairs, information technology, and human resources.

According to the IQVIA MAT Report, DELEX ranked as the third-largest national pharmaceutical company in the hospital channel in the Philippines as of December 2020.

Current Operations

DELEX currently employs approximately 200 staff, maintains over 30 FDA-approved hospital products, and supplies more than 900 pharmacies and hospitals, 160 drug chains, and 380 dispensing physicians and clinics. The company also operates three pharmacy retail locations.

Key Strengths and Expansion Plans

1. Sustained Growth: Fifteen years of consistent business growth supported by strong leadership, in-demand products, and established regional partnerships.



2. Regulatory Strength: Holder of multiple Philippine FDA licenses covering pharmaceutical importation, distribution, medical devices, cosmetics, food products, and retail drugstores, including online delivery operations.



3. Product Expansion: Portfolio includes over 30 FDA-approved hospital products, with 11 new pharmaceutical launches and expanding medical device offerings.



4. Medical Devices: Strategic alliances with global manufacturers such as Amsino, Masimo, and Verathon to grow its medical device segment.



5. Retail Pharmacy Growth: Plans to expand pharmacy locations to up to 60 stores, strategically located near hospitals and high-traffic areas.


6. ePharmacy Platform: Continued expansion of its 24/7 online pharmacy and delivery services to meet rising digital healthcare demand.



7. Global Engagement: The DELEX ICU Forum, now a global online educational platform, has reached nearly 200,000 healthcare professionals worldwide.



8. Infrastructure & Logistics: Ongoing investments in warehouse expansion, trade sales teams, and SAP ERP systems to enhance operational efficiency.



9. Strategic Acquisition: Acquisition of JMN Brothers Pharma Limited to expand into women’s health and beauty product segments.



10. Quality Assurance: ISO 9001:2015 re-certification, demonstrating commitment to international quality standards.



11. Industry Recognition: Multiple awards, including CEO of the Year 2025, Best Employer Brand Award 2025, and SME Company of the Year.


Market Opportunity

Asia’s pharmaceutical market exceeds US$600 billion, while the medical device market surpasses US$110 billion, driven by population growth, rising healthcare demand, and technological adoption. DELEX is strategically positioned to capture growth through product development, partnerships, and regional expansion.

About DELEX Healthcare Group, Inc. (DELEX)


DELEX is on a mission to revolutionize the pharmaceutical and healthcare industry. As a Delaware-registered company, DELEX partners with JMN Brothers Pharma Limited, Inc. and DLX Holdings, Inc., bringing high-quality products to market. With a focus on innovation, regulatory excellence, and customer service, DELEX strives to meet the growing demands of the market while adhering to the highest standards of regulatory compliance and customer service excellence.


For more information, visit www.delexpharma.com

Even corporate news that shows great numbers performance cant move this ticker off sub penny status.

Delex Pharma Audited Financials - audited by PwC.

Can be found here: https://www.otcmarkets.com/file/company/financial-report/518173/content

Much more to come,

Up 47% now, was up 71% yesterday that is called the true company where everyone should be investing at....Hyorc.com

BNCM is similar to fka GEECF

Seems that way

Fraud is easier to commit in the phillipines.

Its not the audits ...its the fact that management has not done one thing to further the progress of this company for almost two years and counting , no change in management , no ticker change , no uplisting progress , just delay after delay, same old tactic by Hata, He has done the same thing with another company he is involved with for years !!!. With these figures noted in audit the PPS should be in the dollars but have been sub penny for months .

The only false claims here are made by you. BNCM is a joke. Stating falsehoods to the contrary are comical. 

All investors should know that the company's financials have, in fact, been audited by a PCAOB auditor. All claims to the contrary are false.

its amazing that people differentiate truth from facts? How many OTC companies actually provide Audited Financials here? BNCM (DELEX)

How could anyone in their correct mind even think that a company audited by the top accounting firm is a paper company?

A smart enough will know the potential growth of an OTC company with an AUDITED FINANCIALS from one of the biggest accounting firm in world when most never provides any audited financials.

https://www.otcmarkets.com/stock/BNCM/news/BNCM-Delex-Releases-its-Audited-Financials-and-High-Growth-Strategy-for-2026?id=505444

Look for a run to .01-.04 and SELL. Delex is a non operational piece of paper.

mazasif...I too sold about 6 mo ago and now invested in TG...LO which is finally about to FID and RM with Delfin Midstream. your are correct TIME = MONEY ..too much time wasted hear.

Listen, BNCM has posted audited financials, and will change its name, ticker, and so on - it has already filed to accomplish this.

Also, you're not allowed to promote other tickers on BNCM's page; everyone knows investments will pay here.

OMG! Nothing changed with this scam company. I left 6-8 months ago when it went under .01 and invested every penny to this other stock i used to mention here ($HY**OR) which took over AS**PZ (old ticker) via R/M in 2024. This HY**OR went through "Name Change" then ISO certifications (9001, 14001, 45001) then did Ticker Symbol change then completed Financial Auditing 2023-25 then submitted Form 10-12G for uplisting to OTCQB which is due this month and then final stage is NASDAQ in next 3-6months. It is a fully SEC reporting Audited company now. Has achieved Penny Stock Exempt status as well.
Simultaneously, it kept developing its businesses in 3 sectors based on their Patents; Waste to Methanol, HyOrc Power /Energy Grids, Hydrogen Locomotive Retrofits. Currently have many Pilot programs, MOUs, Platform level works, Joint Ventures, Offtake Commitments and Proof of Concepts (POCs). Now waiting on major Contracts in those areas i mentioned above. It is working in 7-8 different countries with subcontractors all around.
Today the company is up 400% in less a month, and about 1300% from its 52 wk lows (.007) where BNCM has been sitting on for last 6 months atleadt and haven't done a shit.

My money ($8k, sold 1m shares) i took from here is sitting at 600% gains at $HY**OR.

Don't waste your time here...it is a total scam to begin with. Time is money 💰 don't waste it anymore.

https://www.otcmarkets.com/stock/BNCM/profile

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175076173

You can post almost anything so long as it doesn't constitute libel, like your accusations against Vic.

Other forms of misinformation will also be deleted. Thanks.

Wouldn't want to disrupt your constant misleading posts. Is that why you removed my FACTUAL OBSERVATIONS?BNCM still floundering. .005-.007 lol

To be honest, there's no reason to even post here - intelligent people see the value. It's just a matter of time. You can talk into the void all you want.

BNCM .005, should see a paint job soon

BNCM is a "Pharmaceutical" company. Its at risk of a CE designation. Here are some sample statements from a promoter: 
3/18/25 "This week may represent the last chance to load up at these levels."
12/16/24 "Best possible time to buy."
12/12/24 "I assume we see the audited financials this month, and the uplist should come in early 2025."
11/17/24 "Dimes, then dollars."

.0069 ask no takers lol 

So why did you claim Vic D wasn't their counsel and now are backing him? No libel, Vic runs pumps. I've watched it for years. BNCM is a PR job located ovseas with only company generated hype and an endless promo here carried out by you. Sue me, LMFAO. Vic will keep it up until all the air is gone from his ticker baloons. 

The company has already proved eight figures in revenue through a PwC audit - it's realer than many Nasdaq companies; there's no debating this.

As for Vic, I disagree with your characterization of him, which is what I consider to be libel. You should stop posting before you get banned. If you have something meaningful to contribute, then do so, but this board is for legitimate BNCM investors and those interested in the company.

Previously you stated Vic was no longer involved. Own up to your lies. BNCM is a non operational pump job.You are the biggest promoter. 

Vic is a skilled and legitimate lawyer, and you're making baseless claims.

BNCM is returning with a vengeance; hop aboard while you can or be left in the dust. 🚀

https://www.otcmarkets.com/stock/BNCM/profile
Vic is the atty
wrong again Humbert

Even if this goes 50x it will dump. The reports are fraudulent and tied to Vic D. His other pump job GREH was fun. 

Ticker change, dividend, up list, etc.

These levels are gifts, so load up while you can. Dividends alone will make people regret not getting in at these prices